Your email has been successfully added to our mailing list.

×
0.000977653631284821 0.00349162011173184 -0.0122905027932962 -0.0212290502793298 -0.065782122905028 -0.0727653631284917 -0.0769553072625699 -0.071927374301676
Stock impact report

Gilead +12% on coronavirus treatment testing [Seeking Alpha]

Gilead Sciences, Inc. (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Company Research Source: Seeking Alpha
On the Move | Healthcare Gilead +12% on coronavirus treatment testing Feb. 3, 2020 6:06 AM ET Gilead Sciences, Inc. (GILD) Yoel Minkoff Shares of Gilead Sciences (NASDAQ: up 12% formalizing "Gilead is working with health authorities in China to establish a randomized, controlled trial to determine whether remdesivir can safely and effectively be used to treat 2019-nCoV," the company said in a statement. "While there are no antiviral data for remdesivir that show activity against 2019-nCoV at this time, available data in other coronaviruses give us hope." Trials for the drug will be conducted in Wuhan, the central Chinese city that is ground zero for the current outbreak. See all stocks on the move » Now read: December Portfolio Update » Show less Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
GILD alerts

from News Quantified
Opt-in for
GILD alerts

from News Quantified